Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid, Chronic-Phase

Explore clinical trials studying Leukemia, Myeloid, Chronic-Phase. Study availability and eligibility vary by location and protocol.

314 public trials 21 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid, Chronic-Phase trial results

Completed

American Ginseng in Treating Patients With Fatigue Caused by Cancer

NCT00719563

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +103 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Aurora Presbyterian Hospital Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
  • Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States
View all 326 locations
View Trial Details
Completed

Sargramostim in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission Following Initial Treatment

NCT00072579

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations
  • CCOP - Western Regional, Arizona Phoenix, Arizona, United States
  • CCOP - Bay Area Tumor Institute Oakland, California, United States
  • CCOP - Mount Sinai Medical Center Miami Beach, Florida, United States
  • Regional Radiation Oncology Center at Rome Rome, Georgia, United States
View all 15 locations
View Trial Details
Completed

Phase IV, Open-label, Multicenter Study of Dasatinib in Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients With Chronic, Low-grade Non-Hematologic Toxicity to Imatinib

NCT01660906

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Phase Chronic Myeloid Leukemia, +12 more
Locations
  • Pacific Cancer Medical Center Anaheim, California, United States
  • Cancer Center Of Central Connecticut Southington, Connecticut, United States
  • St. Agnes Healthcare, Inc. Baltimore, Maryland, United States
  • Promedica Hematology & Oncology Assoicates Sylvania, Ohio, United States
View all 22 locations
View Trial Details
Completed

Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML

NCT00123474

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +12 more
Locations
  • University Of Alabama At Birmingham Birmingham, Alabama, United States
  • Central Hematology Oncology Medical Group Inc. Alhambra, California, United States
  • Pacific Cancer Medical Center Inc Anaheim, California, United States
  • Loma Linda University Cancer Center Loma Linda, California, United States
View all 137 locations
View Trial Details
Completed

Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment

NCT00006348

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +100 more
Locations
  • CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States
  • CCOP - Carle Cancer Center Urbana, Illinois, United States
  • CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States
  • Siouxland Hematology-Oncology Sioux City, Iowa, United States
View Trial Details
Completed

Dasatinib Combination Therapy With the Smoothened (SMO) Inhibitor BMS-833923 in Chronic Myeloid Leukemia (CML)

NCT01218477

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations
  • University Of California Medical Center San Francisco, California, United States
  • Sidney Kimmel Cancer Center At Johns Hopkins Baltimore, Maryland, United States
  • Ut M.D. Anderson Cancer Center Houston, Texas, United States
  • Local Institution Hamilton, Ontario, Canada
View Trial Details

Related conditions